Sweden
· Delayed Price · Currency is SEK Vaxxa AB Statistics
Total Valuation
Vaxxa AB has a market cap or net worth of SEK 43.80 million. The enterprise value is 32.37 million.
| Market Cap | 43.80M |
| Enterprise Value | 32.37M |
Important Dates
The last earnings date was Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 37.17% in one year.
| Current Share Class | 43.37M |
| Shares Outstanding | 43.37M |
| Shares Change (YoY) | +37.17% |
| Shares Change (QoQ) | +14.71% |
| Owned by Insiders (%) | 3.48% |
| Owned by Institutions (%) | n/a |
| Float | 41.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -53.42 |
| EV / Sales | 0.45 |
| EV / EBITDA | 24.34 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.96 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -3.42% and return on invested capital (ROIC) is -2.43%.
| Return on Equity (ROE) | -3.42% |
| Return on Assets (ROA) | -1.64% |
| Return on Invested Capital (ROIC) | -2.43% |
| Return on Capital Employed (ROCE) | -3.00% |
| Revenue Per Employee | 8.92M |
| Profits Per Employee | -75,750 |
| Employee Count | 8 |
| Asset Turnover | 2.60 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.50% in the last 52 weeks. The beta is 0.41, so Vaxxa AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +27.50% |
| 50-Day Moving Average | 0.86 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 67.86 |
| Average Volume (20 Days) | 159,496 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vaxxa AB had revenue of SEK 71.38 million and -606,000 in losses. Loss per share was -0.01.
| Revenue | 71.38M |
| Gross Profit | 141,000 |
| Operating Income | -722,000 |
| Pretax Income | -606,000 |
| Net Income | -606,000 |
| EBITDA | 1.33M |
| EBIT | -722,000 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 11.81 million in cash and 380,000 in debt, giving a net cash position of 11.43 million or 0.26 per share.
| Cash & Cash Equivalents | 11.81M |
| Total Debt | 380,000 |
| Net Cash | 11.43M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 23.68M |
| Book Value Per Share | 0.56 |
| Working Capital | 12.17M |
Cash Flow
| Operating Cash Flow | -3.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 0.20%, with operating and profit margins of -1.01% and -0.85%.
| Gross Margin | 0.20% |
| Operating Margin | -1.01% |
| Pretax Margin | -0.85% |
| Profit Margin | -0.85% |
| EBITDA Margin | 1.86% |
| EBIT Margin | -1.01% |
| FCF Margin | n/a |
Dividends & Yields
Vaxxa AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.17% |
| Shareholder Yield | -37.17% |
| Earnings Yield | -1.38% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |